Two complementary companies, Boehringer Ingelheim and Merial, unite through a passion for animals and a joint

history of integrity, quality and trust.

2017

Boehringer Ingelheim enters into exclusive negotiations with Sanofi consisting of a strategic exchange of their consumer

healthcare business for Merial.

2015

Merial becomes a wholly-owned subsidiary of Sanofi.

2009

Merial was created through the merger of Rhône Mérieux (Rhône-Poulenc, France) and MSD AgVet (Merck & Co, US)

1997

Boehringer Ingelheim’s Animal Health division was established as the company takes over Pfizer’s veterinary

program.

1955

Mérieux founded the Institut Biologique Mérieux (Mérieux Biological Institute), in Lyon, France. This early vaccine research and production center was the starting point for the animal health endeavors that would one day become the

company Merial.

1897

A family-owned company with 28 employees, headquartered in Ingelheim, Germany was founded by Albert Boehringer.

1885

One with the power of two : our History

present in more than

150countries

10,000+employees

20+R&D sites

19Industrial sites

“We are passionate about animal health and recognize the critical importance of serving animal health needs globally, with a special focus on prevention. We know that when animals are healthy, humans are healthier, too.”

JOACHIM HASENMAIERHead of the Boehringer Ingelheim Animal Health Business Unit

Member of the Boehringer Ingelheim Board of Managing Directors

About Boehringer Ingelheim Animal Health

Headquarters

INGELHEIM, GERMANY